While the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively
https://european-biotechnology.com/wp-content/uploads/2024/05/Analyst_Foto_Wieprecht_kl-scaled.jpg14402560Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2022-03-29 10:46:002024-07-18 14:24:29After the setback, what's next for biotech stocks?
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2022-03-29_um_09.29.28.png288558Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-03-29 08:54:522024-04-04 16:47:18Sanofi and IGM Biosciences Inc. in $6.15bn deal
XNK Therapeutics AB has secured a private placement of €12.75m led by Flerie Invest AB to finance Phase II development of CellProtect + Isatuximab in multiple myeloma.
The SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral genetic material extraction. BioEcho Life Sciences, together with Hamilton and the German diagnostics laboratory Labor Dr. Fenner und Kollegen developed an automated workflow for 96- and 48-well plate formats.
Data Management has been a hotbed for development and innovation, correlating primarily with the changing digital landscape. Clinical trial management has been significantly impacted, with the electronic data capture and GDPR-compliance-led industry now unrecognisable from the paper-document administration methods of the past. This development process extends beyond COVID-19 and has a noticeable impact on clinical trials.
https://european-biotechnology.com/wp-content/uploads/2024/04/seite_50.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-03-29 00:00:002024-04-02 16:19:47Mastering the data revolution of clinical trials
ADCs have huge potential in treating challenging diseases such as cancer. However, it is essential that all necessary equipment, steps, and precautions are in place to en¬sure their safe handling.
https://european-biotechnology.com/wp-content/uploads/2024/04/Lonza_sponsored_March_22.jpg12002560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-03-28 06:00:002024-04-02 15:34:50How to Safely Handle Your Antibody Drug Conjugate
https://european-biotechnology.com/wp-content/uploads/2024/04/FIX.jpg298554Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-03-27 06:28:002024-04-04 16:47:20CSL Behring files for MAA of haemophilia B gene therapy
Beijing, China March 22, 2022 Sino Biological, Inc. (Sino Biological or the Company), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce a CRO services partnership with Ainnocence, Inc. of San Jose, California.
Novo Holdings co-leads €40m Qure.ai financing
Latest NewsDeep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and HealthQuad
After the setback, what's next for biotech stocks?
OpinionWhile the Nasdaq Biotechnology index saw a huge uplift during the pandemic (+ 77% since March 2020 until reaching a peak in August 2021), it lost 27% during the last six months vs a 11%/4% decline for the Nasdaq Composite and the S&P 500, respectively
Sanofi and IGM Biosciences Inc. in $6.15bn deal
Latest NewsSanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM $6bn if all milestones are met.
XNK Therapeutics AB raises €12.75m
Latest NewsXNK Therapeutics AB has secured a private placement of €12.75m led by Flerie Invest AB to finance Phase II development of CellProtect + Isatuximab in multiple myeloma.
Automated workflow
Sponsored PublicationsThe SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral genetic material extraction. BioEcho Life Sciences, together with Hamilton and the German diagnostics laboratory Labor Dr. Fenner und Kollegen developed an automated workflow for 96- and 48-well plate formats.
Mastering the data revolution of clinical trials
BackgroundData Management has been a hotbed for development and innovation, correlating primarily with
the changing digital landscape. Clinical trial management has been significantly impacted, with the
electronic data capture and GDPR-compliance-led industry now unrecognisable from the paper-document administration methods of the past. This development process extends beyond COVID-19 and has a
noticeable impact on clinical trials.
How to Safely Handle Your Antibody Drug Conjugate
Sponsored PublicationsADCs have huge potential in treating challenging diseases such as cancer. However, it is essential that all necessary equipment, steps, and precautions are in place to en¬sure their safe handling.
CSL Behring files for MAA of haemophilia B gene therapy
Latest NewsCSL Behring has filed for accelerated approval of the first hemophilia B gene therapy in Europe.
SwedenBIO appoints scientific relations manager
AppointmentsMaja Neiman is the first Science Relations Manager at SwedenBIO. The biotechnologist started her work at the end of March.
Sino Biological and Ainnocence Partner to Offer Next-Generation Antibody Development CRO Services
Sponsored PublicationsBeijing, China March 22, 2022 Sino Biological, Inc. (Sino Biological or the Company), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce a CRO services partnership with Ainnocence, Inc. of San Jose, California.